Javier
Rodríguez Rodríguez
Consultor Médico
Christchurch Hospital
Christchurch, Nueva ZelandaPublikationen in Zusammenarbeit mit Forschern von Christchurch Hospital (1)
2016
-
SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer
Journal of Clinical Oncology, Vol. 34, Núm. 15, pp. 1723-1731